SPARTA, N.J., — PLx Pharma, a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform to provide more effective and safer products, with its lead products Vazalore 325 mg and Vazalore 81 mg liquid-filled aspirin capsules, announced that Vazalore is now on shelves at major retailers and e-commerce sites nationwide.

“We are excited that Vazalore has hit the shelves nationally and look forward to communicating the benefits of this innovative aspirin therapy to millions of patients at risk for vascular disease,” stated Natasha Giordano, chief executive officer of PLx. “We are confident consumers will recognize Vazalore as a breakthrough in aspirin delivery, designed to help protect the stomach while providing all of the benefits of aspirin to help prevent another heart attack or clot-related stroke.”

Vazalore, the first and only U.S. Food and Drug Administration approved liquid-filled aspirin capsules, is available in Vazalore 81 mg, 12 count; Vazalore 81 mg, 30 count and Vazalore 325 mg, 30 count. It is available at more than 30,000 drug, grocery and mass retail stores, including Walmart, CVS, Walgreens, Target, and RiteAid, as well as on e-commerce sites such as Amazon.